PISTIS, MARCO
 Distribuzione geografica
Continente #
EU - Europa 197.026
NA - Nord America 9.052
AS - Asia 4.215
SA - Sud America 655
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
Totale 211.084
Nazione #
IT - Italia 194.732
US - Stati Uniti d'America 8.901
SG - Singapore 1.668
CN - Cina 1.431
SE - Svezia 581
UA - Ucraina 552
BR - Brasile 496
VN - Vietnam 376
DE - Germania 266
GB - Regno Unito 223
FI - Finlandia 220
FR - Francia 213
HK - Hong Kong 182
IN - India 103
CA - Canada 82
KR - Corea 81
BD - Bangladesh 62
AR - Argentina 54
IQ - Iraq 52
NL - Olanda 48
TR - Turchia 40
PL - Polonia 34
MX - Messico 33
AT - Austria 31
ZA - Sudafrica 31
JP - Giappone 27
PK - Pakistan 25
ES - Italia 24
UZ - Uzbekistan 24
RU - Federazione Russa 23
CO - Colombia 21
MA - Marocco 21
ID - Indonesia 20
VE - Venezuela 19
EC - Ecuador 18
CL - Cile 16
SA - Arabia Saudita 16
PH - Filippine 15
IL - Israele 14
BE - Belgio 13
EG - Egitto 13
IE - Irlanda 12
PY - Paraguay 12
CH - Svizzera 11
CZ - Repubblica Ceca 11
KE - Kenya 10
TN - Tunisia 10
EU - Europa 9
JM - Giamaica 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
CR - Costa Rica 8
PE - Perù 8
AU - Australia 7
BO - Bolivia 7
JO - Giordania 7
MY - Malesia 7
DO - Repubblica Dominicana 6
IR - Iran 6
LT - Lituania 6
NP - Nepal 6
ET - Etiopia 5
OM - Oman 5
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
TH - Thailandia 4
AL - Albania 3
CI - Costa d'Avorio 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
BG - Bulgaria 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LY - Libia 2
MU - Mauritius 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
Totale 211.063
Città #
Cagliari 190.374
Uta 3.837
Fairfield 915
Singapore 821
Ashburn 800
Woodbridge 641
San Jose 572
Chandler 426
Houston 420
Boardman 399
Dallas 387
Ann Arbor 383
Seattle 340
Wilmington 338
Nyköping 336
Cambridge 301
Jacksonville 268
Beijing 261
Dearborn 194
Los Angeles 183
Hong Kong 165
Council Bluffs 158
Santa Clara 142
Helsinki 137
Shanghai 130
New York 126
Ho Chi Minh City 119
Hefei 115
Lauterbourg 114
Nanjing 107
Boston 94
Seoul 79
Hanoi 72
Buffalo 67
The Dalles 67
San Diego 53
Guangzhou 49
Dong Ket 46
Milan 45
São Paulo 45
London 40
Frankfurt am Main 39
Munich 39
Nanchang 39
Rome 36
Chicago 35
Hebei 32
Orem 32
Shenyang 32
Atlanta 30
Warsaw 30
Redwood City 29
Redondo Beach 27
Tianjin 27
Baghdad 25
Mountain View 24
Jiaxing 22
Tokyo 22
Toronto 22
Vienna 22
Nuremberg 21
Tashkent 21
Washington 21
Brooklyn 19
Jinan 19
San Francisco 19
Norwalk 18
Da Nang 17
Montreal 17
Changsha 16
Denver 16
Kunming 16
Chennai 15
Johannesburg 15
Haiphong 14
Mexico City 14
Amsterdam 13
Brussels 13
Phoenix 13
Porto Alegre 13
Verona 13
Auburn Hills 12
Augusta 12
Dublin 12
Orange 12
San Mateo 12
Sèlegas 12
Casablanca 11
Taizhou 11
Zhengzhou 11
Cairo 10
New Delhi 10
Poplar 10
Quito 10
Rio de Janeiro 10
Santiago 10
Sassari 10
Shenzhen 10
Wuhan 10
Biên Hòa 9
Totale 205.277
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.768
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.636
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.179
Maternal immune activation disrupts dopamine system in the offspring 4.152
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.484
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.382
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.358
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 3.095
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 3.025
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings 2.955
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.824
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.739
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.723
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.601
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.546
null 2.498
Effects of maternal immune activation on dopamine activity in male and female offspring 2.460
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.459
null 2.394
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.381
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.360
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.311
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.231
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.183
Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: Involvement of the endocannabinoid system 2.169
Trattamenti farmacologici per la dipendenza da nicotina 2.055
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.022
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 2.011
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 2.003
The role of nuclear hormone receptors in cannabinoid function 1.957
Pharmacological treatments for nicotine dependence 1.915
Opposite responses to aversive stimuli in lateral habenula neurons 1.910
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.861
Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors 1.857
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.821
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice 1.821
Cannabinoid withdrawal: where does the hypodopaminergic state come from? 1.809
Neurobiologia della dipendenza da nicotina 1.800
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.799
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases 1.786
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.779
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.772
Characterization of wild-type (R100R) and mutated (Q100Q) GABA(A) alpha(6) subunit in Sardinian alcohol non-preferring rats (sNP) 1.756
Neurobiology of nicotine addiction 1.684
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.664
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.631
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings 1.610
Preclinical studies of cannabis addiction − relationships between the endocannabinoid and dopamine systems 1.608
Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood – A Longitudinal Study 1.577
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features and emerging specificities of the two major endocannabinoids 1.576
The endocannabinoid system and nondrug rewarding behaviours 1.458
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.450
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.425
Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system 1.417
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.397
Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat 1.372
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.367
Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area 1.352
Neurobiological mechanisms of cannabinoid addiction 1.291
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.268
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.166
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.132
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.125
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 1.104
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.098
Endocannabinoids and the processing of value-related signals 1.086
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.062
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 1.039
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.037
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.030
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction 947
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 918
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology 910
Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles 855
null 850
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 842
null 841
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance 832
From surface to nuclear receptors: the endocannabinoid family extends its assets 816
null 800
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 782
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors 764
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 758
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 749
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug-resistant epilepsy (DRE) 747
null 747
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 738
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 721
Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition 718
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 714
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 713
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line 661
Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions 651
Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice 612
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study 608
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus 596
Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation 592
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 572
Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity 515
Older people: forgotten victims amid the Ukrainian humanitarian disaster 513
Totale 198.755
Categoria #
all - tutte 266.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 266.892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.062 0 0 0 0 0 0 0 0 0 0 0 1.062
2021/202211.101 1.050 879 586 682 1.013 908 564 469 602 1.328 1.738 1.282
2022/202313.833 966 1.337 1.295 1.077 1.299 1.630 730 1.290 1.109 1.039 1.411 650
2023/202449.729 650 566 535 849 1.467 2.427 2.628 1.101 927 889 1.632 36.058
2024/202520.925 3.816 4.750 2.828 2.973 1.635 1.653 1.772 185 396 248 377 292
2025/20269.287 861 442 989 783 660 652 1.659 555 627 1.215 580 264
Totale 211.475